The legacy of Viagra and its parent , copyright, presents a complex picture for potential investors. While the iconic drug initially fueled enormous revenues , its exclusivity has expired , leading to rival versions flooding the market . This decline in cost presents a significant obstacle for copyright and any company considering a heavy stake in